HomeCompareNBRY vs PFE

NBRY vs PFE: Dividend Comparison 2026

NBRY yields 512.82% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBRY wins by $74719.32M in total portfolio value
10 years
NBRY
NBRY
● Live price
512.82%
Share price
$0.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74719.37M
Annual income
$54,003,807,702.14
Full NBRY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NBRY vs PFE

📍 NBRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBRYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBRY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBRY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBRY
Annual income on $10K today (after 15% tax)
$43,589.74/yr
After 10yr DRIP, annual income (after tax)
$45,903,236,546.82/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, NBRY beats the other by $45,903,214,226.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBRY + PFE for your $10,000?

NBRY: 50%PFE: 50%
100% PFE50/50100% NBRY
Portfolio after 10yr
$37359.71M
Annual income
$27,001,916,980.43/yr
Blended yield
72.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NBRY
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBRY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBRYPFE
Forward yield512.82%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$74719.37M$49.6K
Annual income after 10y$54,003,807,702.14$26,258.71
Total dividends collected$72929.43M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NBRY vs PFE ($10,000, DRIP)

YearNBRY PortfolioNBRY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$61,982$51,282.05$9,153$693.39+$52.8KNBRY
2$363,383$297,062.31$8,593$849.25+$354.8KNBRY
3$2,016,476$1,627,655.79$8,336$1,066.78+$2.01MNBRY
4$10,598,885$8,441,255.59$8,437$1,384.80+$10.59MNBRY
5$52,806,644$41,465,837.52$9,013$1,875.40+$52.80MNBRY
6$249,582,121$193,079,012.24$10,306$2,680.72+$249.57MNBRY
7$1,119,909,823$852,856,952.70$12,820$4,101.38+$1119.90MNBRY
8$4,774,834,551$3,576,531,040.71$17,673$6,826.70+$4774.82MNBRY
9$19,360,340,566$14,251,267,596.86$27,543$12,591.86+$19360.31MNBRY
10$74,719,372,108$54,003,807,702.14$49,560$26,258.71+$74719.32MNBRY

NBRY vs PFE: Complete Analysis 2026

NBRYStock

Newberry Specialty Bakers, Inc. produces bakery products for grocery stores and food services industry. It offers scones, pastries, brownies, cakes, cheesecakes, cookies, single serves, pies, pie shells, and Latin deserts. Newberry Specialty Bakers, Inc. was formerly known as Coastal Foods, Inc. and changed its name to Newberry Specialty Bakers, Inc. in November 2015. The company was founded in 1990 and is based in Houston, Texas. On July 3, 2018, the voluntary petition of Newberry Specialty Bakers, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on October 13, 2017.

Full NBRY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NBRY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBRY vs SCHDNBRY vs JEPINBRY vs ONBRY vs KONBRY vs MAINNBRY vs JNJNBRY vs MRKNBRY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.